These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1069 related items for PubMed ID: 9725263

  • 21. Intermediate TCR cells can induce graft-versus-host disease after allogeneic bone marrow transplantation.
    Weerasinghe A, Kawamura T, Moroda T, Seki S, Watanabe H, Abo T.
    Cell Immunol; 1998 Apr 10; 185(1):14-29. PubMed ID: 9636679
    [Abstract] [Full Text] [Related]

  • 22. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM, Gorechlad J, Larsen CP, Waller EK.
    Biol Blood Marrow Transplant; 2006 Dec 10; 12(12):1239-49. PubMed ID: 17162205
    [Abstract] [Full Text] [Related]

  • 23. Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens.
    Friedman TM, Jones SC, Statton D, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2004 Apr 10; 10(4):224-35. PubMed ID: 15077221
    [Abstract] [Full Text] [Related]

  • 24. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
    Shizuru JA, Jerabek L, Edwards CT, Weissman IL.
    Biol Blood Marrow Transplant; 1996 Feb 10; 2(1):3-14. PubMed ID: 9078349
    [Abstract] [Full Text] [Related]

  • 25. Mechanism of protection from graft-versus-host disease mortality by IL-2. III. Early reductions in donor T cell subsets and expansion of a CD3+CD4-CD8- cell population.
    Abraham VS, Sachs DH, Sykes M.
    J Immunol; 1992 Jun 15; 148(12):3746-52. PubMed ID: 1534824
    [Abstract] [Full Text] [Related]

  • 26. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses.
    Korngold R.
    Bone Marrow Transplant; 1992 May 15; 9(5):355-64. PubMed ID: 1352163
    [Abstract] [Full Text] [Related]

  • 27. Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome.
    Blazar BR, Taylor PA, Snover DC, Sehgal SN, Vallera DA.
    J Immunol; 1993 Nov 15; 151(10):5726-41. PubMed ID: 8228258
    [Abstract] [Full Text] [Related]

  • 28. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC, Song CW, Blazar BR, Vallera DA.
    J Immunol; 1985 Aug 15; 135(2):941-6. PubMed ID: 3891856
    [Abstract] [Full Text] [Related]

  • 29. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
    Bhattacharyya S, Cowan MJ.
    Biol Blood Marrow Transplant; 2005 Sep 15; 11(9):657-71. PubMed ID: 16125636
    [Abstract] [Full Text] [Related]

  • 30. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ.
    J Clin Invest; 1998 May 01; 101(9):1835-42. PubMed ID: 9576746
    [Abstract] [Full Text] [Related]

  • 31. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
    Blazar BR, Hirsch R, Gress RE, Carroll SF, Vallera DA.
    J Immunol; 1991 Sep 01; 147(5):1492-503. PubMed ID: 1831826
    [Abstract] [Full Text] [Related]

  • 32. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.
    Friedman TM, Statton D, Jones SC, Berger MA, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2001 Sep 01; 7(1):2-13. PubMed ID: 11215694
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Vallera DA.
    J Immunol; 1998 Jun 01; 160(11):5355-65. PubMed ID: 9605135
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C, Hirano T, Miyajima H, Okumura K, Ovary Z, Hashimoto H.
    J Immunol; 1995 Mar 15; 154(6):2687-96. PubMed ID: 7876541
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H, LeGuern C, Sachs DH, Sykes M.
    Bone Marrow Transplant; 1996 Aug 15; 18(2):285-92. PubMed ID: 8864436
    [Abstract] [Full Text] [Related]

  • 40. Short-term homing assay reveals a critical role for lymphocyte function-associated antigen-1 in the hepatic recruitment of lymphocytes in graft-versus-host disease.
    Sato T, Habtezion A, Beilhack A, Schulz S, Butcher E, Thorlacius H.
    J Hepatol; 2006 Jun 15; 44(6):1132-40. PubMed ID: 16466827
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.